The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro.
N. Bukreyeva, E. K. Mantlo, R. A. Sattler, C. Huang, S. Paessler, J. Zeldis
This study shows that the IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro by reducing viral titers by up to 4 logs after overnight pretreatment.
bioRxiv · Apr 7, 2020 · PreprintMicrobiology